Metro-3 Phase 2 And Final Stretch Of Samruddhi Expressway Likely To Open On May 1; PM Modi May Inaugurate Projects According to sources, efforts are underway to inaugurate both projects through ...

Metro Line 3 Phase 2 Opens Up Connecting BKC To Worli; Over 26K Commuters Take Ride On Day 1 After Opening For Public Despite the seamless connectivity and the official launch on a weekend ...

This paper presents a new three-phase phase-locked loop (PLL) system that primarily estimates the phase angles, frequency, and magnitudes of the a three-phase input signal and also provides a filtered ...

This letter proposes a phase-locked loop (PLL) able to operate as an independent single-phase PLL in the context of three-phase systems. Its key advantage is that the extracted information allows the ...

The Soo Locks SAULT STE. MARIE, Mich. — U.S. Army Corps of Engineers, Detroit District’s New Lock at the Soo project in Sault Ste. Marie, Michigan, awards a total of $95.3 million for remaining Phase ...

Firmware supporting the Application Note AN3607 'Phase Sequence Detection of Three Phase AC Supply'. This application demonstrates phase sequence detection, RMS voltage measurement on the three-phase ...

Introduction Genetic and clinical evidence has shown that interleukin-33 plays a key role in the susceptibility and progression of asthma. The phase 2a FRONTIER-3 study ([NCT04570657][1]) investigated ...

In the Phase 3 VISIONARY study, sibeprenlimab achieved a statistically significant and clinically meaningful 51.2% (P<0.0001) reduction in proteinuria at nine months of treatment when compared to ...

Otsuka Pharmaceutical has shared more detailed data behind its kidney disease drug’s phase 3 win, showing the monoclonal antibody halved patients’ urine protein-to-creatinine ratio (UPCR) levels.

In potential good news for Prothena, Roche announced earlier this week that it will advance Prothena-partnered prasinezumab into phase 3 trials for early-stage Parkinson’s disease, despite the ...

Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug for vision-robbing disease wet age-related macular degeneration (AMD), throwing its future into doubt ...

June 18, 2025 — 07:42 am EDT Written by None for Quiver Quantitative -> Biogen launches Phase 3 BRAVE study to assess omaveloxolone's effects in children with Friedreich ataxia. Quiver AI Summary ...